GH Workshop banner

Providing you with an outlook on the clinical disruption in CRC, Lung and Breast Cancer influenced by MRD monitoring, join this Guardant Health workshop to discuss the latest MRD trends showcased by innovative use cases in early-stage disease.

Leveraging latest technological progress in focal amplification detection, the workshop will also delve deep in the uncovering of copy number alterations to enroll patients in relevant biomarker-informed late-stage cancer trials.